Beata M Wolska

Prof. Beata M Wolska


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2011 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
WLWilliam E. Louch
William E. Louch
KSKatherine A. Sheehan
Katherine A. Sheehan
BWBeata M Wolska
Beata M Wolska

16 April 1999 in Circulation Research
Verified
Journal Article
Closed access
PDF file
BWBeata M Wolska
Beata M Wolska
RKRebecca S. Keller
Rebecca S. Keller
CEChristian C. Evans
Christian C. Evans
KPKimberly A. Palmiter
Kimberly A. Palmiter
RPRonald M. Phillips
Ronald M. Phillips
RSR. John Solaro
R. John Solaro
—We compared the dynamics of the contraction and relaxation of single myocytes isolated from nontransgenic (NTG) mouse hearts and from transgenic (TG-β-Tm) mouse hearts that overexpress the skeletal isoform of tropomyosin (Tm). Compared with NTG controls, TG-β-Tm myocytes showed significantly reduced maximal rates of contraction and relaxation with no change in the extent of shortening. This result indicated that the depression in contraction dynamics determined in TG-β-Tm isolated hearts is intrinsic to the cells. To further investigate the effect of Tm isoform switching on myofilament activity and regulation, we measured myofilament force and ATPase rate as functions of pCa (−log of [Ca 2+ ]). Compared with controls, force generated by myofilaments from TG-β-Tm hearts and myofibrillar ATPase activity were both more sensitive to Ca 2+ . However, the shift in pCa 50 (half-maximally activating pCa) caused by changing sarcomere length from 1.8 to 2.4 μm was not significantly different between NTG and TG-β-Tm fiber preparations. To test directly whether isoform switching affected the economy of contraction, force versus ATPase rate relationships were measured in detergent-extracted fiber bundles. In both NTG and TG-β-Tm preparations, force and ATPase rate were linear and identically correlated, which indicated that crossbridge turnover was unaffected by Tm isoform switching. However, detergent extracted fibers from TG-β-Tm demonstrated significantly less maximum tension and ATPase activity than NTG controls. Our results provide the first evidence that the Tm isoform population modulates the dynamics of contraction and relaxation of single myocytes by a mechanism that does not alter the rate-limiting step of crossbridge detachment. Our results also indicate that differences in sarcomere-length dependence of activation between cardiac and skeletal muscle are not likely due to differences in the isoform population of Tm.

1 November 2001 in The Journal of Physiology
Verified
Journal Article
Closed access
PDF file
BWBeata M Wolska
Beata M Wolska
KVKalpana Vijayan
Kalpana Vijayan
GAGrace M. Arteaga
Grace M. Arteaga
JKJohn P. Konhilas
John P. Konhilas
RPRonald M. Phillips
Ronald M. Phillips
RSR. John Solaro
R. John Solaro

1 April 2014 in Circulation: Cardiovascular Genetics
Verified
Journal Article
Closed access
PDF file
MAMarco L. Alves
Marco L. Alves
FDFernando A.L. Dias
Fernando A.L. Dias
RGRobert D. Gaffin
Robert D. Gaffin
JSJillian N. Simon
Jillian N. Simon
EMEric M. Montminy
Eric M. Montminy
BWBeata M Wolska
Beata M Wolska
Background—: Hypertrophic cardiomyopathy (HCM) is a common genetic disorder caused mainly by mutations in sarcomeric proteins and is characterized by maladaptive myocardial hypertrophy, diastolic heart failure, increased myofilament Ca 2+ sensitivity, and high susceptibility to sudden death. We tested the following hypothesis: correction of the increased myofilament sensitivity can delay or prevent the development of the HCM phenotype. Methods and Results—: We used an HCM mouse model with an E180G mutation in α-tropomyosin (Tm180) that demonstrates increased myofilament Ca 2+ sensitivity, severe hypertrophy, and diastolic dysfunction. To test our hypothesis, we reduced myofilament Ca 2+ sensitivity in Tm180 mice by generating a double transgenic mouse line. We crossed Tm180 mice with mice expressing a pseudophosphorylated cardiac troponin I (S23D and S24D; TnI-PP). TnI-PP mice demonstrated a reduced myofilament Ca 2+ sensitivity compared with wild-type mice. The development of pathological hypertrophy did not occur in mice expressing both Tm180 and TnI-PP. Left ventricle performance was improved in double transgenic compared with their Tm180 littermates, which express wild-type cardiac troponin I. Hearts of double transgenic mice demonstrated no changes in expression of phospholamban and sarcoplasmic reticulum Ca 2+ ATPase, increased levels of phospholamban and troponin T phosphorylation, and reduced phosphorylation of TnI compared with Tm180 mice. Moreover, expression of TnI-PP in Tm180 hearts inhibited modifications in the activity of extracellular signal-regulated kinase and zinc finger-containing transcription factor GATA in Tm180 hearts. Conclusions—: Our data strongly indicate that reduction of myofilament sensitivity to Ca 2+ and associated correction of abnormal relaxation can delay or prevent development of HCM and should be considered as a therapeutic target for HCM.

1 December 2011 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
DTDomenico M. Taglieri
Domenico M. Taglieri
MMMichelle M. Monasky
Michelle M. Monasky
IKIvana Knezevic
Ivana Knezevic
KSKatherine A. Sheehan
Katherine A. Sheehan
MLMing Lei
Ming Lei
RSR. John Solaro
R. John Solaro

1 December 2010 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
JPJames R. Peña
James R. Peña
ASAriani C. Szkudlarek
Ariani C. Szkudlarek
CWChad M. Warren
Chad M. Warren
LHLynley S. Heinrich
Lynley S. Heinrich
RGRobert D. Gaffin
Robert D. Gaffin
BWBeata M Wolska
Beata M Wolska